journal article·2018-04-09

Quantum Dots Elicit Hepatotoxicity through Lysosome-Dependent Autophagy Activation and Reactive Oxygen Species Production

Jiajun Fan, Shaofei Wang, Xuyao Zhang, Wei Chen, Yubin Li, Ping Yang, Zhonglian Cao, Yichen Wang, Weiyue Lu, Dianwen Ju

Publisher page

Abstract

Quantum dots (QDs) were reported to be metabolized by the liver and demonstrated to be toxic in vitro and in vivo with unclear mechanisms, which largely limited their applications in the field of biomedical research. To improve their biosafety, the mechanism of how the QDs triggered hepatotoxicity was evaluated in this study. We found that CdTe/CdS QDs can trigger significant apoptosis-independent nanotoxicity after their uptake by liver cells and internalization into lysosomes. Besides, the lysosomal enzymes were abnormally activated after the QDs entered the lysosomes, which caused reactive oxygen species (ROS) production and autophagy activation. Importantly, inhibition of lysosomal enzymes not only rescued the viability of liver cells but also blocked the production of ROS and activation of autophagic flux, whereas inhibition of ROS and autophagy could ameliorate the hepatotoxicity induced by QDs but had no impact on the activity of lysosomal enzymes. Our results elucidate the relationship among the lysosomes, ROS, and autophagy in QDs-induced hepatotoxicity, which indicate that the QDs can elicit hepatotoxicity through lysosome-dependent autophagy activation and ROS production, highlighting an approach to improve the biosafety of QDs by lysosomal inhibition.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Autophagy in Disease and Therapy · Carbon and Quantum Dots Applications · Cassava research and cyanide

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai 201199, P. R. China

Department of Microbiological and Biochemical Pharmacy and Key Lab of Smart Drug Delivery MOE, School of Pharmacy, Fudan University, Shanghai 201203, P. R. China

Instrumental Analysis Center, School of Pharmacy, Fudan University, Shanghai, 201203, P. R. China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Special Research Foundation of State Key Laboratory of Medical Genomics and Collaborative Innovation Center of Systems Biomedicine

References (60)

Show source-provided references
1. 10.1007/s00204-007-0253-y10.1007/s00204-007-0253-y ↗
2. 10.1002/jat.290010.1002/jat.2900 ↗
3. 10.1166/jnn.2010.248110.1166/jnn.2010.2481 ↗
4. 10.1016/j.toxlet.2015.02.00410.1016/j.toxlet.2015.02.004 ↗
5. Al-Rasheed N. M. · Eur. Rev. Med. Pharmacol. Sci. · 2014 · 18 · 1813
6. 10.1186/1743-8977-10-4010.1186/1743-8977-10-40 ↗
7. 10.1021/nn302649p10.1021/nn302649p ↗
8. 10.3762/bjnano.6.1110.3762/bjnano.6.11 ↗
9. 10.1186/1556-276X-8-19810.1186/1556-276X-8-198 ↗
10. 10.1021/nn502466z10.1021/nn502466z ↗
11. 10.3109/17435390.2010.53971210.3109/17435390.2010.539712 ↗
12. 10.1016/j.taap.2013.06.00410.1016/j.taap.2013.06.004 ↗
13. 10.1039/c3mt20234h10.1039/c3mt20234h ↗
14. 10.1186/1556-276X-8-25410.1186/1556-276X-8-254 ↗
15. 10.1111/j.1348-0421.2004.tb03478.x10.1111/j.1348-0421.2004.tb03478.x ↗
16. 10.1016/j.chemosphere.2015.04.04410.1016/j.chemosphere.2015.04.044 ↗
17. 10.2147/IJN.S7830810.2147/IJN.S78308 ↗
18. 10.1016/j.biomaterials.2012.05.05110.1016/j.biomaterials.2012.05.051 ↗
19. 10.1016/j.biomaterials.2013.08.03810.1016/j.biomaterials.2013.08.038 ↗
20. 10.1021/nn401961910.1021/nn4019619 ↗
21. 10.1002/smll.20080097210.1002/smll.200800972 ↗
22. 10.2147/IJN.S3965810.2147/IJN.S39658 ↗
23. 10.1021/ar300058510.1021/ar3000585 ↗
24. 10.1371/journal.pone.002440610.1371/journal.pone.0024406 ↗
25. 10.1007/s11356-015-5035-010.1007/s11356-015-5035-0 ↗
26. 10.1038/nrm356510.1038/nrm3565 ↗
27. 10.1016/j.lfs.2015.03.02010.1016/j.lfs.2015.03.020 ↗
28. 10.1016/j.ymgme.2015.08.00110.1016/j.ymgme.2015.08.001 ↗
29. 10.1016/j.semcancer.2015.08.00110.1016/j.semcancer.2015.08.001 ↗
30. 10.1038/srep1242510.1038/srep12425 ↗
31. Gao W. · Int. J. Clin. Exp. Med. · 2015 · 8 · 3401
32. 10.3892/etm.2015.243210.3892/etm.2015.2432 ↗
33. 10.1371/journal.pone.011697210.1371/journal.pone.0116972 ↗
34. 10.18632/oncotarget.223210.18632/oncotarget.2232 ↗
35. 10.1016/j.biomaterials.2015.05.02910.1016/j.biomaterials.2015.05.029 ↗
36. 10.1039/C4NR02008A10.1039/C4NR02008A ↗
37. 10.1021/acsnano.5b0043910.1021/acsnano.5b00439 ↗
38. 10.1016/j.biomaterials.2014.05.00710.1016/j.biomaterials.2014.05.007 ↗
39. 10.1016/j.taap.2015.08.00410.1016/j.taap.2015.08.004 ↗
40. 10.1021/nn305567s10.1021/nn305567s ↗
41. 10.1016/j.biomaterials.2015.11.02910.1016/j.biomaterials.2015.11.029 ↗
42. 10.4161/auto.3618710.4161/auto.36187 ↗
43. 10.4161/auto.1949610.4161/auto.19496 ↗
44. 10.1016/j.biomaterials.2013.07.08710.1016/j.biomaterials.2013.07.087 ↗
45. 10.1159/00001356110.1159/000013561 ↗
46. 10.1074/jbc.M70222320010.1074/jbc.M702223200 ↗
47. 10.1016/j.biomaterials.2013.09.04810.1016/j.biomaterials.2013.09.048 ↗
48. 10.1016/j.biomaterials.2011.10.07010.1016/j.biomaterials.2011.10.070 ↗
49. 10.1016/j.biomaterials.2011.12.02310.1016/j.biomaterials.2011.12.023 ↗
50. 10.1016/j.actbio.2016.10.02210.1016/j.actbio.2016.10.022 ↗
51. 10.1021/nn100561e10.1021/nn100561e ↗
52. 10.1039/c3nr04037b10.1039/c3nr04037b ↗
53. 10.1016/j.biomaterials.2012.06.06010.1016/j.biomaterials.2012.06.060 ↗
54. 10.1002/adhm.20130006610.1002/adhm.201300066 ↗
55. 10.1007/s12011-014-0068-710.1007/s12011-014-0068-7 ↗
56. 10.1007/978-94-017-8739-0_710.1007/978-94-017-8739-0_7 ↗
57. 10.1016/j.jfda.2014.01.00510.1016/j.jfda.2014.01.005 ↗
58. 10.1016/j.imlet.2013.11.01910.1016/j.imlet.2013.11.019 ↗
59. 10.1016/j.tibs.2013.08.00910.1016/j.tibs.2013.08.009 ↗
60. 10.3389/fnana.2014.0008310.3389/fnana.2014.00083 ↗